S
BIIB icon

Sachetta’s Biogen BIIB Stock Holding History

Sachetta’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Buy
97
+27
+39% +$5.17K 0.01% 290
2026
Q1 		$12.8K Hold
70
– – 0.01% 385
2025
Q4 		$12.3K Hold
70
– – 0.01% 358
2025
Q3 		$9.81K Hold
70
– – ﹤0.01% 467
2025
Q2 		$8.79K Buy
70
+42
+150% +$5.23K ﹤0.01% 471
2025
Q1 		$3.83K Sell
28
-1
-3% -$143 ﹤0.01% 622
2024
Q4 		$4.43K Sell
29
-37
-56% -$6.24K ﹤0.01% 617
2024
Q3 		$12.8K Sell
66
-30
-31% -$6.28K 0.01% 427
2024
Q2 		$20.3K Buy
96
+25
+35% +$5.43K 0.01% 337
2024
Q1 		$18.4K Hold
71
– – 0.01% 323
2023
Q4 		$18.4K Buy
+71
New +$17.4K 0.01% 323

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Sachetta's BIIB Position: Q2 2026 in Review

Sachetta increased its Biogen (BIIB) stake by 39% in Q2 2026, buying an estimated $5.17K and bringing the position to 97 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #290.

Sachetta first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. 218 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Sachetta held 97 shares of Biogen worth $21K as of Q2 2026.
  • Sachetta bought 27 Biogen shares in Q2 2026, an estimated $5.17K.
  • Biogen made up 0.01% of Sachetta's portfolio in Q2 2026, its #290 holding.
  • Sachetta first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • 218 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.